Several reports showed that circulating TRAIL levels were lower in patients diagnosed with CAD vs. those undiagnosed [20,21,22,23], associating with oxidative stress [67] and disease severity [16,17]. This evidence concerns the gene TNFSF10 and coronary artery disorder.